← Return to Chinese Medicine: Breath, Balance, and the Turning Seasons

Study · verified by the research team

Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi)

Nortier JL, Martinez MC, Schmeiser HH, et al. · 2000 · New England Journal of Medicine 342(23): 1686–1692

https://doi.org/10.1056/NEJM200006083422301

Showed high prevalence of urothelial cancer among Belgian patients with Chinese-herb nephropathy, with aristolochic-acid DNA adducts in all tissues.

Study details

DesignClinical-pathological study of prophylactically removed kidneys and ureters
Population39 patients with end-stage Chinese-herb nephropathy
OutcomeUrothelial carcinoma; aristolochic acid–DNA adducts
Finding18 of 39 (46%) had urothelial carcinoma; all samples contained aristolochic-acid DNA adducts; cumulative doses >200 g associated with higher risk
LimitationsSingle cohort; no unexposed comparison group
Certaintyhigh

Cited by (2)

Chapters (1)

Atlas entrys (1)